1. The FDA’s drug shortages task force will ultimately present a report to Congress that frames the causes of the problem and offers recommendations to address the ongoing crisis. The public can comment on the agency’s November meeting on drug shortages until January 11, 2019. You can add your voice there by sharing how drug shortages have impacted you and what solutions you’d like Congress to implement.
  2. The Affordable Drug Manufacturing Act would make it possible for the government to step in during shortages and produce lifesaving drugs. Find out more. Call your member of Congress.
  3. Understanding a complex problem like drug shortages would be easier if you could see how the Big Pharma supply chain operates. The Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act would usher in greater transparency in the industry. Find out more. Call your Senator.
  4. Limited competition in U.S. drug manufacturing connects to rising prices and shortages. Though the effort has been opposed by pharma industry groups, the FDA is currently studying the import of drugs from other countries at the direction of President Trump. Call the White House.